1-800-798-3353 rxmail@rxconsultant.com
Optimal Time to Donate Plasma After COVID-19 Infection

Optimal Time to Donate Plasma After COVID-19 Infection

Convalescent plasma, a COVID-19 immunotherapy, was granted emergency use authorization by the FDA in August 2020 for treatment of hospitalized patients early in the course of COVID-19 infection. According to a new study, the optimal time for donating convalescent...
EpiPen® Expiration Extended

EpiPen® Expiration Extended

Many factors, including supply disruptions and manufacturing problems, have contributed to shortages of the EpiPen® (epinephrine) auto-injector. To help mitigate the shortage, the FDA has extended the expiration date (beyond the 20-month shelf life) for specific lots...

ASHP updates policies, procedures for drug shortages

The American Society of Health-System Pharmacists (ASHP) has released updated guidance on the management of drug shortages, which focuses on policies and procedures that help minimize the effects of drug shortages on the quality of care. “The current situation of drug...
New Guideline on Blood Pressure Targets for Older Adults

New Guideline on Blood Pressure Targets for Older Adults

Appropriate blood pressure (BP) goals for older adults have been debated in recent years. A 2014 guideline ignited controversy by increasing the traditional goal (< 140/90 mmHg) to less than 150/90 for patients age 60 and older. Since then, additional evidence has...
New Hepatitis C Treatment

New Hepatitis C Treatment

Vosevi™, a new single tablet treatment for hepatitis C (HCV), combines 2 previously approved drugs, sofosbuvir and velpatasvir, and a new drug, voxilaprevir. It is approved for patients with chronic HCV of any genotype (1-6), with or without mild liver disease, who...